相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TUDCA Ameliorates Liver Injury Via Activation of SIRT1-FXR Signaling in a Rat Hemorrhagic Shock Model
Silei Sun et al.
SHOCK (2020)
Aberrant MUC1 accumulation in salivary glands of Sjogren's syndrome patients is reversed by TUDCA in vitro
Isabel Castro et al.
RHEUMATOLOGY (2020)
Effect of 4-Phenylbutyric Acid and Tauroursodeoxycholic Acid on Magnesium and Calcium Metabolism in Streptozocin-Induced Type 1 Diabetic Mice
Qi Zhou et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2019)
TUDCA-Treated Mesenchymal Stem Cells Protect against ER Stress in the Hippocampus of a Murine Chronic Kidney Disease Model
Jun Hee Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer
Sandhya Chipurupalli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory
Yingpeng Xu et al.
MICROBIAL CELL FACTORIES (2019)
The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression
Anna Walczak et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?
Leonardo Baiocchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Bile Acid TUDCA Improves Beta-Cell Mass and Reduces Insulin Degradation in Mice With Early-Stage of Type-1 Diabetes
Gabriela Alves Bronczek et al.
FRONTIERS IN PHYSIOLOGY (2019)
TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrPc
Yeo Min Yoon et al.
REDOX BIOLOGY (2019)
The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
Yoshimitsu Kiriyama et al.
BIOMOLECULES (2019)
TUDCA attenuates intestinal injury and inhibits endoplasmic reticulum stress-mediated intestinal cell apoptosis in necrotizing enterocolitis
Peng Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt-induced renal injury and inflammation
Carmen De Miguel et al.
ACTA PHYSIOLOGICA (2019)
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome
Siamak MahmoudianDehkordi et al.
ALZHEIMERS & DEMENTIA (2019)
The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis
Hangqi Luo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling
Young Hoon Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway
Huan Yu et al.
ONCOLOGY REPORTS (2019)
Conjugated bile acids attenuate allergen-induced airway inflammation and hyperresposiveness by inhibiting UPR transducers
Emily M. Nakada et al.
JCI INSIGHT (2019)
Tauroursodeoxycholic acid (TUDCA) counters osteoarthritis by regulating intracellular cholesterol levels and membrane fluidity of degenerated chondrocytes
Yoshie Arai et al.
BIOMATERIALS SCIENCE (2019)
Effect of tauroursodeoxycholic acid on PUFA levels and inflammation in an animal and cell model of hepatic endoplasmic reticulum stress
M. Aslan et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2018)
Tauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice
Xuesong Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease
Weijun Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl- channels
Qin Li et al.
HEPATOLOGY (2018)
Tauroursodeoxycholic Acid Protects against the Effects of P-Cresol-Induced Reactive Oxygen Species via the Expression of Cellular Prion Protein
Seung Pil Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells
Magdalena Kusaczuk et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles
Stewart F. Graham et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease
Alexandra Isabel Rosa et al.
MOLECULAR NEUROBIOLOGY (2018)
Tauroursodeoxycholic acid (TUDCA) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation
Ying Zhang et al.
PLOS ONE (2018)
Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model
Seung Han Kim et al.
ONCOLOGY LETTERS (2018)
Anti-inflammatory effect of Tauroursodeoxycholic acid in RAW 264.7 macrophages, Bone marrow-derived macrophages, BV2 microglial cells, and spinal cord injury
Seong Jun Kim et al.
SCIENTIFIC REPORTS (2018)
Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
Rui Feng et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Nebojsa Pavlovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cholestatic liver diseases: new targets, new therapies
Priscila Santiago et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease
Stewart E. Graham et al.
METABOLITES (2018)
Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy
Nathalie Launay et al.
ACTA NEUROPATHOLOGICA (2017)
The role of endoplasmic reticulum stress in neurodegenerative disease
Chunchen Xiang et al.
APOPTOSIS (2017)
TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation
Natalia Yanguas-Casas et al.
MOLECULAR NEUROBIOLOGY (2017)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease
Sara Moreira et al.
EXPERIMENTAL NEUROLOGY (2017)
Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis
Annelies Paridaens et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
Andi Marquardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Tauroursodeoxycholic Acid Reduces Arterial Stiffness and Improves Endothelial Dysfunction in Type 2 Diabetic Mice
Micah L. Battson et al.
JOURNAL OF VASCULAR RESEARCH (2017)
Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review
Duminda Suraweera et al.
LIVER INTERNATIONAL (2017)
Tauroursodeoxycholic acid inhibits TNF-α-induced lipolysis in 3T3-L1 adipocytes via the IRE-JNK-perilipin-A signaling pathway
Wenyan Xia et al.
MOLECULAR MEDICINE REPORTS (2017)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation
Dongdong Sun et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Gargi Ganguly et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice
Jean Franciesco Vettorazzi et al.
SCIENTIFIC REPORTS (2017)
Protein Quality Control by Molecular Chaperones in Neurodegeneration
Aaron Ciechanover et al.
FRONTIERS IN NEUROSCIENCE (2017)
Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death
Jagadeesh Kumar Uppala et al.
SCIENTIFIC REPORTS (2017)
Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease
Alexandra I. Rosa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Troxerutin Attenuates Enhancement of Hepatic Gluconeogenesis by Inhibiting NOD Activation-Mediated Inflammation in High-Fat Diet-Treated Mice
Zifeng Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Post translational modification of Parkin
Joy Chakraborty et al.
BIOLOGY DIRECT (2017)
Effect of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Metabolism of Copper and Zinc in Type 1 Diabetic Mice Model
Qi Zhou et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2016)
The TUDCA trial - innovative trial designs for amyotrophic lateral sclerosis drugs?
A. C. Ludolph
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
A. E. Elia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease
Jalahalli M. Siddesha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective
Sha Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Effects of bile acids on neurological function and disease
Matthew McMillin et al.
FASEB JOURNAL (2016)
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
Hong Ma et al.
MEDICINE (2016)
The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells
Jean Franciesco Vettorazzi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13
Ga-Young Park et al.
ONCOLOGY LETTERS (2016)
Bile Acids in Neurodegenerative Disorders
Hayley D. Ackerman et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Epigenetics: from the past to the present
Nubia Andrea Villota-Salazar et al.
FRONTIERS IN LIFE SCIENCE (2016)
Tauroursodeoxycholic acid prevents stress induced aggregation of proteins in vitro and promotes PERK activation in HepG2 cells
Amina R. Gani et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes
Ana Paula Arruda et al.
CELL METABOLISM (2015)
Phenylbutyric Acid: Simple Structure - Multiple Effects
Magdalena Kusaczuk et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Tauroursodeoxycholic acid suppresses endoplasmic reticulum stress in the chondrocytes of patients with osteoarthritis
Chao Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Critical Role of Endoplasmic Reticulum Stress in Cognitive Impairment Induced by Microcystin-LR
Fei Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease
Leonardo M. Cortez et al.
JOURNAL OF VIROLOGY (2015)
Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration
Violeta Gomez-Vicente et al.
PLOS ONE (2015)
Glycolipid Metabolism Disorder in the Liver of Obese Mice Is Improved by TUDCA via the Restoration of Defective Hepatic Autophagy
Qinyue Guo et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure
Yves-Paul Vandewynckel et al.
ONCOTARGET (2015)
Classification of Chemical Chaperones Based on Their Effect on Protein Folding Landscapes
Rohan Dandage et al.
ACS CHEMICAL BIOLOGY (2015)
Effects of Tauroursodeoxycholic Acid and Alpha-Lipoic-Acid on the Visual Response Properties of Cat Retinal Ganglion Cells: An In Vitro Study
Huika Xia et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
TUDCA Promotes Phagocytosis by Retinal Pigment Epithelium via MerTK Activation
Hiromi Murase et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Tauroursodeoxycholic Acid Attenuates Progression of Steatohepatitis in Mice Fed a Methionine-Choline-Deficient Diet
Eun-Ju Cho et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects
Agustina Noailles et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
Natalia Yanguas-Casas et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The therapeutic potential of chemical chaperones in protein folding diseases
Leonardo Cortez et al.
PRION (2014)
Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review
David Q-H Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Reversal of glucose intolerance in rat offspring exposed to ethanol before birth through reduction of nuclear skeletal muscle HDAC expression by the bile acid TUDCA
Xing-Hai Yao et al.
PHYSIOLOGICAL REPORTS (2014)
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li et al.
PHARMACOLOGICAL REVIEWS (2014)
Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cells
Tomohiro Omura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Synthesis and Evaluation of Water-Soluble Prodrugs of Ursodeoxycholic Acid (UDCA), an Anti-apoptotic Bile Acid
Peter I. Dosa et al.
CHEMMEDCHEM (2013)
Molecular Chaperone ORP150 in ER Stress-related Diseases
Magdalena Kusaczuk et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes
E. Panzhinskiy et al.
DIABETOLOGIA (2013)
Tauroursodeoxycholate, a Chemical Chaperone, Prevents Palmitate-induced Apoptosis in Pancreatic β-cells by Reducing ER Stress
Q. Zhu et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
α5β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes
Holger Gohlke et al.
HEPATOLOGY (2013)
β1 integrin is a long-sought sensor for tauroursodeoxycholic acid
Ulrich Beuers
HEPATOLOGY (2013)
Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial
Xiao-li Pan et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
Adrian C. Lo et al.
NEUROBIOLOGY OF DISEASE (2013)
TAUROURSODEOXYCHOLIC ACID PROTECTS RETINAL NEURAL CELLS FROM CELL DEATH INDUCED BY PROLONGED EXPOSURE TO ELEVATED GLUCOSE
J. M. Gaspar et al.
NEUROSCIENCE (2013)
Prenatal Ethanol Exposure Causes Glucose Intolerance with Increased Hepatic Gluconeogenesis and Histone Deacetylases in Adult Rat Offspring: Reversal by Tauroursodeoxycholic Acid
Xing-Hai Yao et al.
PLOS ONE (2013)
Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
Li Fang et al.
PLOS ONE (2013)
Restoration of the Unfolded Protein Response in Pancreatic β Cells Protects Mice Against Type 1 Diabetes
Feyza Engin et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
Martina Duefer et al.
DIABETES (2012)
Ursodeoxycholic acid for nonalcoholic steatohepatitis
Sheng-di Wu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Amelioration of Glucolipotoxicity-Induced Endoplasmic Reticulum Stress by a Chemical Chaperone in Human THP-1Monocytes
Raji Lenin et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
Elaine Studer et al.
HEPATOLOGY (2012)
A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus
Maria Galan et al.
HYPERTENSION (2012)
Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
Magd A. Kotb
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress
James G. Cash et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
Ju-Hong Min et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
TUDCA, a Bile Acid, Attenuates Amyloid Precursor Protein Processing and Amyloid-β Deposition in APP/PS1 Mice
Ana F. Nunes et al.
MOLECULAR NEUROBIOLOGY (2012)
Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson's Disease
M. Castro-Caldas et al.
MOLECULAR NEUROBIOLOGY (2012)
Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells
Hong Sung Chun et al.
TOXICOLOGY (2012)
Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action
Raoul Poupon
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy
Kahori Shiba-Fukushima et al.
SCIENTIFIC REPORTS (2012)
Chemical Chaperone TUDCA Preserves Cone Photoreceptors in a Mouse Model of Leber Congenital Amaurosis
Tao Zhang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
TUDCA Slows Retinal Degeneration in Two Different Mouse Models of Retinitis Pigmentosa and Prevents Obesity in Bardet-Biedl Syndrome Type 1 Mice
Arlene V. Drack et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis
Ersin Seyhun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
Alexander Wree et al.
DIGESTION (2011)
In PSC with Colitis Treated with UDCA, Most Colonic Carcinomas Develop in the First Years After the Start of Treatment
G. Rudolph et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure
Wagner S. da-Silva et al.
FEBS LETTERS (2011)
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction
Asli F. Ceylan-Isik et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration
Brian C. Oveson et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
Dimosthenis Mantopoulos et al.
PLOS ONE (2011)
Mitochondrial Dysfunction in Parkinson's Disease
P. C. Keane et al.
PARKINSONS DISEASE (2011)
Tauroursodeoxycholic Acid Prevents Retinal Degeneration in Transgenic P23H Rats
Laura Fernandez-Sanchez et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress
Yeon Yi Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis
Gareth J. Parry et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
Marleen Kars et al.
DIABETES (2010)
Rescue of Cystathionine β-Synthase (CBS) Mutants with Chemical Chaperones PURIFICATION AND CHARACTERIZATION OF EIGHT CBS MUTANT ENZYMES
Tomas Majtan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid
Yong Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Bile acids as regulatory molecules
Phillip B. Hylemon et al.
JOURNAL OF LIPID RESEARCH (2009)
Converging concepts of protein folding in vitro and in vivo
F. Ulrich Hartl et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus
Alena Viktorinova et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Bear bile: dilemma of traditional medicinal use and animal protection
Yibin Feng et al.
JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE (2009)
Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals
Guenther Boden et al.
DIABETES (2008)
Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKCα-/PKA-dependent mechanism in rat liver
R. Wimmer et al.
GUT (2008)
Endoplasmic Reticulum Stress Markers Are Associated with Obesity in Nondiabetic Subjects
Neeraj K. Sharma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N. Cullen et al.
JOURNAL OF HEPATOLOGY (2008)
Protein misfolding in conformational disorders: Rescue of folding defects and chemical chaperoning
Paula Leandro et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
Rita M. Ramalho et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30
M. Joe Phillips et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis
Joana D. Amaral et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes
Rui E. Castro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Davide Festi et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs
Tsutomu Arakawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid β-peptide-induced apoptosis
Susana Sola et al.
MOLECULAR ENDOCRINOLOGY (2006)
Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells
Rita M. Ramalho et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Ursodeoxycholic acid treatment of vanishing bile duct syndromes
Thomas Pusl et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts
M Marzioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver
F Dombrowski et al.
LABORATORY INVESTIGATION (2006)
Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
Ulrich Beuers
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-β1-induced apoptosis in rat hepatocytes
S Solá et al.
HEPATOLOGY (2005)
A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid
RE Castro et al.
JOURNAL OF HEPATOLOGY (2005)
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis
C Rust et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β-peptide-induced apoptosis of PC12 Cells
RM Ramalho et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways
MH Schoemaker et al.
HEPATOLOGY (2004)
The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons
RE Castro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways
G Alpini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Therapeutic approaches to protein-misfolding diseases
FE Cohen et al.
NATURE (2003)
Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor β1-induced apoptosis of rat hepatocytes
S Solá et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tauroursodeoxycholic acid prevents amyloid-β peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway
S Solá et al.
MOLECULAR MEDICINE (2003)
Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis
D Häussinger et al.
GASTROENTEROLOGY (2003)
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
G Paumgartner et al.
HEPATOLOGY (2002)
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic model of Huntington's disease
CD Keene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hepatoprotection with tauroursodeoxycholate and β muricholate against taurolithocholate induced cholestasis:: involvement of signal transduction pathways
P Milkiewicz et al.
GUT (2002)
Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes
F Azzaroli et al.
HEPATOLOGY (2002)
Tauroursodeoxycholic acid mobilizes α-PKC after uptake in human HepG2 hepatoma cells
H Glasova et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: Relevance to the cytoprotective function of ursodeoxycholate
C Bernstein et al.
PHARMACOLOGY (2002)
Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione
A Colell et al.
HEPATOLOGY (2001)
A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease
CD Keene et al.
EXPERIMENTAL NEUROLOGY (2001)
Tauroursodesoxycholate-induced choleresis involves p38MAPK activation and translocation of the bile salt export pump in rats
AK Kurz et al.
GASTROENTEROLOGY (2001)
Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver
U Beuers et al.
HEPATOLOGY (2001)
Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: Evidence for a mitochondrial pathway independent of the permeability transition
CMP Rodrigues et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Bilirubin and amyloid-β peptide induce cytochrome c release through mitochondrial membrane permeabilization
CMP Rodrigues et al.
MOLECULAR MEDICINE (2000)